O ur aim was to assess the local extent of osteocyte death in the proximal femur of 16 patients with osteonecrosis of the femoral head. We performed histological examination of the femoral heads and cancellous bone biopsies from four regions of the proximal femur in patients undergoing total hip arthroplasty. A control group consisted of 19 patients with osteoarthritis. All histological specimens were examined in a blinded fashion.
Extensive osteonecrosis was shown in the proximal femur up to 4 cm below the lesser trochanter in the group with osteonecrosis. There was an overall statistically significant difference in the extent of osteocyte death distal to the femoral head between the two groups (p < 0.001). We discuss the implications of these findings as possible contributing factors in regard to the early failure of total hip arthroplasty reported in patients with osteonecrosis of the femoral head.
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Osteonecrosis of the femoral head (ONFH) is a painful and progressive disorder which often leads to collapse and the development of disabling secondary osteoarthritis. The most frequently advocated treatment for advanced ONFH is total hip arthroplasty (THA). Up to 10% of all THAs are performed for ONFH and the mean age of the patients with ONFH undergoing THA is 38 years. 1 Although THA can relieve pain and restore function it is extremely unlikely that the current generation of implants will last for the approximate 40 years of life expectancy of these patients. In addition, the published results of THA in ONFH are disappointing when compared with other groups of patients. In a review of 27 published series, all except two studies reported a higher rate of failure in patients with ONFH than in age-matched patients with other disorders.
1
The reason for this is unknown. A potential cause of premature loosening of the femoral component in patients with ONFH is abnormal cancellous bone at the implantbone and cement-bone interfaces leading to a failure of fixation. 2 We have therefore investigated the hypothesis that osteonecrosis is not confined to the femoral head but may extend distally into areas of cancellous bone crucial for fixation of the implant.
Patients and Methods
After approval of the local Ethical Committee we recruited 16 patients with non-traumatic, advanced ONFH (stages III to IV according to the criteria of Ficat and Arlet) 3 who were undergoing cemented THA (Table I ). There were nine men and seven women with a mean age of 43 years (SD 13.03). Nineteen patients with advanced osteoarthritis of the hip who were having THA served as a control group. There were 11 men and eight women with a mean age of 70 years (SD 10.39). They had no radiological evidence of osteonecrosis. At THA, the femoral head of each patient was removed and placed in 10% buffered formalin solution. Samples of cancellous bone (0.25 cm 3 ) were taken from the following four areas: the base of the femoral neck, the greater trochanter, the lesser trochanter and the medullary canal approximately 4 cm from the lesser trochanter (Fig. 1) . All bone samples were harvested before reaming of the femoral canal and were then stored in buffered formalin. Identical techniques for bone sampling were used in both groups. All the samples were individually coded to ensure that the histological examination was carried out in a 'blind' manner.
The femoral heads were sectioned in the coronal plane at 0.5 cm intervals. Undecalcified samples were embedded in resin, stained with Goldner's trichrome and Toluidine Blue and examined for evidence of underlying metabolic bone disease. Decalcified samples were embedded in paraffin wax and stained with Mayer's haematoxylin and eosin. The samples were then examined for evidence of ONFH and graded according to the histological stages of Arlet and Durroux 4 as follows: type 1, disappearance of the haemopoietic marrow, separation of the lipocytes by oedema or haemorrhage and the presence of foam cells; type 2, necrosis of the fatty marrow; type 3, medullary and trabecular necrosis; and type 4, complete necrosis with dense medullary fibrosis and formation of new bone in apposition to the dead trabeculae. Samples of the proximal femur were decalcified and embedded in paraffin wax before staining with Mayer's haematoxylin and eosin. The presence of empty osteocyte lacunae was used to determine the extent of osteocyte death according to the method of Humphreys et al. 5 The percentage of empty osteocytic lacunae was calculated in ten high-power fields. Simple image-analysis techniques were used to perform the count of osteocytic lacunae, the examiner being unaware of the underlying diagnosis of each specimen. A score of 0 to 3 was then given to each bone sample according to the extent of empty osteocytic lacunae as follows: 0, no evidence of empty osteocyte lacunae; 1, <30%; 2, 30% to 60%; and 3, >60% of empty osteocyte lacunae. Potential problems with this technique such as artefactual cell loss during processing and nuclei remaining within lacunae long after cell death were minimised by using a standard technique to allow a valid comparison of populations of osteocytes within various groups. 6, 7 Statistical analysis. A power calculation was performed which showed that 15 patients would be required in each group to show a 50% difference between the groups using a level of significance of 5%. Statistical analysis of the total score for empty osteocyte lacunae was performed using the Mann-Whitney U test. The risk of osteonecrosis in each case was assessed by making osteonecrosis a qualitative variable (osteonecrosis was either present or absent). Odds ratios and their exact confidence intervals were then calculated together with the p values for Fisher's exact test for the hypothesis that the odds ratio is one. The level of significance was set at p < 0.05.
Results
In the control group there was no evidence of ONFH on plain radiographs of the femoral heads and osteoarthritis was confirmed by histological examination of the femoral heads. By contrast, all cases of ONFH had features of advanced osteonecrosis on plain radiographs (stage III or IV). Histological examination confirmed type-3 or type-4 disease. In all patients metabolic bone disease was histologically excluded. For the proximal femora, the total score for empty osteocyte lacunae for the four regions was calculated by the summation of the scores for each of the patients (Table II) . In contrast to the sporadic occurrence of osteonecrosis in the proximal femur in the control group there was extensive osteonecrosis in specimens with ONFH. The scores for the ONFH group were significantly greater in all four regions (Table III) .
When osteonecrosis was made a qualitative variable there was evidence of its presence in 42 of 64 samples from the ONFH group and in only ten of 76 samples in the control group. There was a statistically significant difference between the ONFH group and the control group in all regions of the proximal femur (Table III) .
Discussion
Yamamoto, DiCarlo and Bullough 8 have recently reported that an increase in the size of lesions in osteonecrosis is extremely rare. They propose that ONFH is due to a single ischaemic event. Approximately 50% of patients with ONFH, however, have osteonecrotic lesions elsewhere suggesting that the disease may be systemic rather than being isolated to the femoral head. 9 This view is supported by a recent study which has shown abnormalities in the bone marrow of the iliac crest of patients with ONFH. 10 Our aim was to assess the local extent of osteocyte death beyond the femoral head. Since the ONFH group in our study involved only 16 patients with various aetiologies the findings must be considered as preliminary, but they suggest that osteonecrosis may cause bone changes in areas remote from the clinical manifestations of the disease. It is possible that the presence of empty osteocyte lacunae in ten out of 76 samples from the control group may have been caused by the harvesting and preparation of the tissues (the preparation techniques were identical in both groups). Evidence of empty osteocyte lacunae in bone from 'normal' subjects, however, has been documented previously and the percentage of non-viable osteocytes is known to increase with age (a mean of 26% by the eighth decade of life).
11 Therefore since the control group had an older mean age, it would be expected that the percentage of empty osteocyte lacunae would be greater in this group. In fact, the opposite was observed with a statistically significant increase in osteocyte death up to 4 cm distal to the lesser trochanter in the ONFH group. Certain prethrombotic conditions such as sickle-cell disease are, by definition, systemic. It may be argued that widespread osteonecrotic lesions may be expected in such diseases because of multiple geographically disparate infarcts. We therefore examined the histological results in the 12 patients with ONFH who did not have sickle-cell disease (Table I ) and in whom there was no history of a prethrombotic condition. Statistical analysis continued to give a significant difference in the degree of osteonecrosis between the ONFH group and the control group in all areas of the proximal femur (Table III) Adequate fixation of a femoral component is dependent on the establishment of an initial mechanical interlock with the adjacent bone of the femoral canal. 2 If a stable interlock is achieved, osseointegration may occur and ensure longterm fixation of the prosthesis. Osseointegration, however, depends on normal cancellous bone with normal remodelling characteristics. Skeletal turnover continues and the bone which is involved in the interlock with the prosthetic implant is not exempt from this turnover. Therefore factors which influence skeletal turnover and skeletal remodelling may affect the long-term fixation of an implant. Preparation of the femoral canal by the reaming of normal cancellous bone may itself produce localised areas of osteonecrosis which may then remodel during the process of osseointegration. In our study histological analysis has shown that in patients with ONFH the bone in regions of the proximal femur corresponding to zones 1, 2, 6 and 7 of Gruen, McNeice and Amstutz 16 is not normal but has evidence of extensive osteocyte death. The presence of osteonecrosis in these regions before reaming of the femoral canal may reduce the remodelling capacity of bone at the implant-bone or implant-cement interface. This may impair the establishment of osseointegration and thereby prevent adequate long-term fixation of the prosthesis. To our knowledge, the observation that osteonecrosis extends into the proximal femur has not previously been documented. We believe that this new finding may be an important factor in the explanation for higher rates of early prosthetic loosening reported in patients undergoing THA for ONFH.
